总时间（秒）：7.79
问答时间（秒）：7.18

Based on the provided literature, I will extract and standardize the required information according to the predefined JSON framework.

**Variants Include**

* Gene: LRRK2
* Variants:
	+ HGVS: NM_032175.3:c.6085G>A (standardized via API)
	+ cDNA Change:
		- Transcript: NM_032175.3
		- Ref: G
		- Alt: A
		- Position: 6085
	+ Protein Change:
		- Ref: G
		- Alt: S
		- Position: 2029 (Note: The position is based on the protein change, not the cDNA position)
	+ Description in input context: I2020T and G2019S

**Described Disease**

* Described Disease: Parkinson's disease
* MONDO: MONDO:0005505 (retrieved from MONDO database)

**Experiment Method**

* Assay Method: Binding assays and Enzymatic assays
* Material used:
	+ Material Source: Not specified
	+ Material Name: Not specified
	+ Description: Not specified
* Readout type: Quantitative
* Readout description:
	+ Variants: NM_032175.3:c.6085G>A
	+ Conclusion: Altered ATP affinity
	+ Molecular Effect: N.D.
	+ Result Description: G2019S has approximately 2-fold lower and I2020T has approximately 6-fold higher ATP affinity than wild-type LRRK2.

**Biological replicates**

* Biological replicates: Not specified

**Technical replicates**

* Technical replicates: Not specified

**Basic positive control**

* Basic positive control: Not specified

**Basic negative control**

* Basic negative control: Not specified

**Validation controls P/LP**

* Validation controls P/LP: N.D.

**Validation controls B/LB**

* Validation controls B/LB: N.D.

**Statistical analysis method**

* Statistical analysis method: N.D.

**Threshold for normal readout**

* Threshold for normal readout:
	+ Source: Literature
	+ Description: Not specified

**Threshold for abnormal readout**

* Threshold for abnormal readout:
	+ Source: Literature
	+ Description: Not specified

**Approved assay**

* Approved assay: No (Note: The experimental methods are not generally used for studying Parkinson's disease)

The extracted information is organized according to the predefined JSON framework.